Hyperthermic potentiation: biological aspects and applications to radiation therapy.
Experimental studies have provided evidence that hyperthermia may be an effective agent, either alone or in combination with ionizing radiation, in the treatment of cancer. Results have shown that temperatures in the range of 42 degrees to 45 degrees C: 1) are cytotoxic, with cell lethality showing little or no dependence on levels of oxygenation; 2) inhibit the recovery of cells from sub-lethal and potentially lethal radiation damage while enhancing the levels of lethal damage; and 3) may be combined with x-irradiation in a manner to improve therapeutic ratios. The observed interaction between hyperthermia and x-rays may in part be due to differences in the Age Response Functions and reassortment of cycling cells to these two agents. Hyperthermia may also greatly change repopulation and re-oxygenation parameters in irradiated tumor and normal tissue volumes. An overall consideration of these and other factors is essential in the design of optimal schedules of combined hyperthermia and x-irradiation treatments in the management of malignant disease.
D000818:Animals; D002455:Cell Division / Q000528:radiation effects; D002470:Cell Survival / Q000528:radiation effects; D002478:Cells, Cultured; D005260:Female; D006358:Hot Temperature / Q000009:adverse effects; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000532:radiotherapy / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000532:radiotherapy / Q000628:therapy; D010100:Oxygen; D011836:Radiation Tolerance; D051381:Rats; D012867:Skin / Q000473:pathology / Q000528:radiation effects
D010100:Oxygen